The right antibiotics, sooner: How 5 systems cut length of stay for patients with bloodstream infections

Bloodstream infections are a significant cause of sepsis, which costs the U.S. healthcare system an estimated $62 billion annually.

Quick and effective antibiotic therapy in patients with sepsis can reduce the risk of death 8 percent per hour. Achieving both timely and optimal therapy hinges on a single variable — the speed at which organism identification and antibiotic susceptibility testing is produced by the clinical microbiology laboratory.

This whitepaper outlines how five health systems improved antibiotic stewardship metrics for patients with bloodstream infections and decreased length of stay by one day using rapid antibiotic susceptibility testing.

Download the whitepaper for insights from:
  • MD Anderson Cancer Center (Houston)
  • Cedars Sinai (Los Angeles)
  • University of Iowa Hospitals & Clinics (Iowa City)
  • Allegheny Health Network (Pittsburgh, Pa.)
  • University of Arkansas for Medical Sciences (Little Rock)

Please fill out the form to download the whitepaper.